Estrella Immunopharma (ESLA) Stock Chart & Stock Price History $0.86 +0.02 (+2.86%) Closing price 08/1/2025 03:58 PM EasternExtended Trading$0.86 0.00 (0.00%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Estrella Immunopharma Stock Price Performance The Estrella Immunopharma (ESLA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 40.41%, with a year-to-date return of -28.00%. In the past month, the stock has decreased 1.93%, reflecting recent market activity. As of the latest close, Estrella Immunopharma traded at $0.86 with a market cap of $31.25 million and volume of 10,927 shares. Receive ESLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.09%1 Month Performance-1.93%3 Month Performance-25.52%Year-To-Date Performance-28.00%1 Year Performance-40.41% ESLA Stock Chart for Saturday, August, 2, 2025 ESLA Chart by TradingView Estrella Immunopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$0.84$0.86+2.86%$0.87$0.8310,927 shs$31.25 million07/31/2025$0.88$0.84-4.00%$0.88$0.827,874 shs$30.38 million07/30/2025$0.90$0.88-3.10%$0.92$0.8620,393 shs$31.65 million07/29/2025$0.92$0.90-1.85%$0.95$0.878,206 shs$32.66 million07/28/2025$0.90$0.92+2.00%$0.94$0.8815,314 shs$33.27 million07/25/2025$0.95$0.90-5.00%$0.95$0.9017,014 shs$32.62 million07/24/2025$0.90$0.95+5.50%$0.95$0.8612,131 shs$34.34 million07/23/2025$0.87$0.90+2.97%$0.93$0.8576,000 shs$32.55 million07/22/2025$0.84$0.87+4.05%$0.92$0.8421,219 shs$31.61 million07/21/2025$0.85$0.84-1.55%$0.92$0.8313,777 shs$30.38 million Get the Latest News and Ratings for ESLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$0.82$0.85+4.04%$0.86$0.835,056 shs$30.86 million07/17/2025$0.84$0.82-2.92%$0.86$0.8219,700 shs$29.66 million07/16/2025$0.84$0.84+1.05%$0.88$0.8314,720 shs$30.55 million07/15/2025$0.89$0.84-5.54%$0.87$0.7840,333 shs$30.24 million07/14/2025$0.88$0.89+0.58%$0.89$0.818,396 shs$32.01 million07/11/2025$0.92$0.88-4.76%$0.92$0.864,240 shs$31.83 million07/10/2025$0.90$0.92+3.11%$0.96$0.887,095 shs$33.42 million07/09/2025$0.87$0.90+2.82%$0.91$0.864,318 shs$32.41 million07/08/2025$0.88$0.87-1.17%$0.92$0.8614,236 shs$31.52 million07/07/2025$0.92$0.88-4.58%$0.95$0.8538,839 shs$31.89 million07/04/2025$0.92$0.92$0.96$0.8616,938 shs$33.42 million07/03/2025$0.88$0.92+4.88%$0.96$0.8616,938 shs$33.42 million07/02/2025$0.86$0.88+2.35%$0.96$0.869,306 shs$31.87 million07/01/2025$0.96$0.86-10.33%$0.96$0.854,358 shs$31.14 million Related Companies Protara Therapeutics Stock Chart Tenaya Therapeutics Stock Chart Inhibikase Therapeutics Stock Chart Anebulo Pharmaceuticals Stock Chart BioHarvest Sciences Stock Chart FitLife Brands Stock Chart Spero Therapeutics Stock Chart Cardiol Therapeutics Stock Chart Atossa Genetics Stock Chart Coherus Oncology Stock Chart Receive ESLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESLA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ESLA Stock Alerts